Evidence map›Paper›PMID 35062984›Full record

ArticleJournal of orthopaedic surgery and research2022

Why and how to use the body's own stem cells for regeneration in musculoskeletal disorders: a primer.

John P Furia, Mark A Lundeen, Jason L Hurd, David A Pearce, Christopher Alt, Eckhard U Alt, Christoph Schmitz, Nicola Maffulli

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

John P FuriaSUN Orthopedics of Evangelical Community Hospital, Lewisburg, PA, USA.
Mark A LundeenSanford Orthopedics & Sports Medicine Fargo, Fargo, ND, USA.
Jason L HurdSanford Orthopedics & Sports Medicine Sioux Falls, Sioux Falls, SD, USA.
David A PearceSanford Research, Sioux Falls, SD, USA.
Christopher AltInGeneron, Inc., TX, Houston, USA.
Eckhard U AltSanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
Christoph SchmitzInstitute of Anatomy, Faculty of Medicine, LMU Munich, Pettenkoferstr. 11, 80331, Munich, Germany. christoph_schmitz@med.uni-muenchen.de.ORCID http://orcid.org/0000-0002-4065-1241
Nicola MaffulliDepartment of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Salerno, Italy.
Ludwig-Maximilians-Universität München · DECommunity Hospital · USSanford Health · USUniversity of Salerno · ITUniversity of South Dakota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the management of musculoskeletal disorders with the patients' own stem cells, isolated from the walls of small blood vessels, which can be found in great numbers in the adipose tissue, has received considerable attention. On the other hand, there are still misconceptions about these adipose-derived regenerative cells (ADRCs) that contain vascular-associated pluripotent stem cells (vaPS cells) in regenerative medicine.

methodsBased on our previous publications on this topic, we have developed a concept to describe the significance of the ADRCs/vaPS cells in the field of orthobiologics as briefly as possible and at the same time as precisely as possible.

resultsThe ADRCs/vaPS cells belong to the group of orthobiologics that are based on autologous cells. Because the latter can both stimulate a patient's body's localized self-healing power and provide new cells that can integrate into the host tissue during the healing response when the localized self-healing power is exhausted, this group of orthobiologics appears more advantageous than cell-free orthobiologics and orthobiologics that are based on allogeneic cells. Within the group of orthobiologics that are based on autologous cells, enzymatically isolated, uncultured ADRCs/vaPS cells have several advantages over non-enzymatically isolated cells/microfragmented fat as well as over uncultured bone marrow aspirate concentrate and cultured cells (adipose-derived stem cells, bone marrow-derived mesenchymal stem cells).

conclusionsThe use of ADRCs/vaPS cells can be seamlessly integrated into modern orthopedic treatment concepts, which can be understood as the optimization of a process which-albeit less efficiently-also takes place physiologically. Accordingly, this new safe and effective type of treatment is attractive in terms of holistic thinking and personalized medicine.

Indexed as

Adipose TissueBone RegenerationStem Cell TransplantationCell- and Tissue-Based TherapyHumansMusculoskeletal DiseasesPluripotent Stem CellsRegenerative MedicineTransplantation, AutologousAdipose-derived regenerative cellsAdipose-derived stem cellsADRCsADSCsBone regenerationCartilage regenerationEfficacyPoint of care treatmentStem cellTendon healing without scar formationTendon regenerationvaPS cells

Identifiers

PMID35062984
PMCPMC8781360
OpenAlexW4206183259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.